Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Companies / Canada

Patheon Reports Problems In Puerto Rico

August 2006 | Company Finance Alert

Canadian contract manufacturing organisation (CMO) Patheon has reported continued problems at manufacturing facilities in Puerto Rico. The company purchased local firm MOVA for US$350mn in 2004, but has reportedly struggled to improve performance and find savings since the

Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.

[
: *
[
: *

Forgotten your password?

If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.

If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.

Free Trial To Pharmaceuticals & Healthcare Insight

TAKE A TRIAL >>
Related Insight Articles
Biovail Restructures Operations

Industry / Canada Following disappointing financial results, Canadian firm Biovail has revealed a restructuring plan. The drugmaker will close two foreign manufacturing plants and will increasingly focus on developing...
May 2008
Patheon Moves To Stem Loses

Companies / Canada Canadian contract drugmaker Patheon has bitten the bullet and put its loss making plant in Carolina, Puerto Rico up for sale, much to the relief of BMI. Rightly in our opinion, the company has seen the...
December 2007
Patheon Blames Operating Environment For Loses

Companies / Canada Troubled Canadian contract drugmaker Patheon is blaming its Puerto Rico operations for the company's latest set of poor quarterly results, which once again failed to meet
September 2007
BMI Sees Solid Market Growth Ahead

Companies / Canada Growth in the pharmaceuticals market in Canada should continue to be steady in the short term, at about 8% per annum in local currency terms, with moderation of expansion expected in the medium term....
November 2006
Steady Growth Expected In Canada's Generics Market

Companies / Canada These positive prospects aside, the expansion of Canada's generics market is likely to meet resistance. In 2006, US pharmaceutical companies again lobbied their government to make Canada's patenting...
May 2006


All material on this site is protected by international copyright laws and use of this site is subject to our Terms & Conditions.
© 2008 Business Monitor International Ltd
Site powered by WORKSsitebuilder CMS